• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.71% Nasdaq Down 0.63%

    Pernix Therapeutics Holdings, Inc. (PTX)

    -NasdaqGM
    0.65 Sep 23, 4:00PM EDT
    |Pre-Market : 0.67 Up 0.02 (2.99%) 8:50AM EDT - Nasdaq Real Time Price
    Prev Close:0.65
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:3.00
    Beta:1.83086
    Earnings Date:Nov 3 - Nov 7 (Est.)
    Day's Range:N/A - N/A
    52wk Range:0.39 - 4.24
    Volume:0
    Avg Vol (3m):5,662,010
    Market Cap:55.29M
    P/E (ttm):N/A
    EPS (ttm):-2.39
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for PTX

    Comparison

    Symbol% ChgMkt Cap
    PTX 0.00%55.29M
    JNJ325.05B
    PFE207.81B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):0.34
    Ex-Dividend Date:21-Aug-01

    Analysts

    Annual EPS Est (Dec-16) :-0.37
    Quarterly EPS Est (Sep-16) :-0.06
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):-0.42

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products. The company’s products comprise Treximet, a medication indicated for the acute treatment of migraine a... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback